Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


NEO New Oncology AG closes financing round


Cologne, October 09, 2015 – NEO New Oncology AG, a Cologne based cancer diagnostics company, today announced the closing of a financing round with a total investment of app. EUR 5 Million.

“I am pleased by the strong interest that NEO New Oncology AG has received from the investment community,” commented Dr Andreas Jenne, CEO of NEO New Oncology AG. “Together with the proceeds from the first closing earlier this year, the funds will help us to make NEOliquid, a genomic diagnostics test that identifies all therapeutically actionable genome alterations from a simple blood sample, available to patients even faster.”

About NEO New Oncology AG

NEO New Oncology AG’s proprietary pan-cancer diagnostic platform ‘NEO’ empowers physicians to select the optimal targeted therapy for their patients, including participation in suitable clinical trials. NEO reliably detects actionable genetic alterations with short turn-around times in routine clinical specimens such as paraffin embedded tissue, cytology or blood. In contrast to conventional testing, NEO identifies all types of therapeutically relevant alterations, i.e. point mutations, amplifications, insertions/deletions, as well as novel and selected known translocations, from one single patient sample. NEO New Oncology AG works with a tumor board of renowned cancer experts, facilitating translation of the latest targeted therapy findings into optimized patient care.

Contact
Dr Jutta Fritz
NEO New Oncology AG
press@newoncology.de

akampion
Dr. Ludger Wess / Ines-Regina Buth
Tel. +49 40 88 16 59 64
Tel. +49 30 23 63 27 68
neo@akampion.com


Publisher Contact Information:

New Oncology
-
press@newoncology.de

Company profile of NEO New Oncology
Past press releases of NEO New Oncology.

Data


23,641
Tech investments
From our Online Data Service
15,266
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 10€2.3MSoftware development
Dec 5€26.0MEnergy related
Dec 5€5.5MSecurity
Dec 5€16.0MKnowledge management
Dec 4€25.0MBiopharmaceuticals
Dec 4€8.0MInternet services
Dec 4€4.3MOptics & Photonics

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Aug 17
Komed Health
komed health closes seed financing round

Jul 10
Komed Health
komed health to be supported by nokia and deutsche telekom

May 4
Vivet Therapeutics
vivet therapeutics raises €37.5 million in series a

Apr 5
Fliit
logistik-start-up fliit sammelt 1.5 millionen bei seed-finanzierung...

Jan 24
Spendesk
in addition to online payments, spendesk is now tackling travel exp...





About usContact usLegal Information
Copyright © 1999-2017
Emerging Technology Research Europe Inc. All rights reserved.